Clostridium perfringens type A enterotoxin damages the rabbit colon

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2211-2218

  Garcia, Jorge P ^a   Li, Jihong ^b   Shrestha, Archana ^b   Freedman, John C ^b   Beingesser, Juliann ^a   McClane, Bruce A ^b   Uzal, Francisco A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CLAUDIN 3; CLAUDIN 4; CLOSTRIDIUM TOXIN; ENTEROTOXIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; ENTEROTOXIN, CLOSTRIDIUM;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CLOSTRIDIUM PERFRINGENS TYPE A; COLON; COLON INJURY; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HISTOLOGY; MALE; NONHUMAN; OSMOLARITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SMALL INTESTINE; WESTERN BLOTTING; YOUNG ADULT; ANIMAL; CLOSTRIDIUM INFECTION; CLOSTRIDIUM PERFRINGENS; DISEASE MODEL; DRUG EFFECTS; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT; TOXICITY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; COLON; DISEASE MODELS, ANIMAL; ENTEROTOXINS; GASTROINTESTINAL DISEASES; RABBITS;

EID: 84900433005     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01659-14     Document Type: Article

References (37)

1. McClane BA, Robertson SL, Li J. 2013. Clostridium perfringens, p 465-89. In Doyle MP, Buchanan RL (ed), Food Microbiology: fundamentals and frontiers, 4th ed. ASM Press, Washington, DC.
2. Sarker MR, Carman RJ, McClane BA. 1999. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol. Microbiol. 33:946-958. http://dx.doi.org/10.1046/j.1365-2958.1999.01534.x.
3. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M, Roy S, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15. http://dx.doi.org/10.3201/eid1701.P11101.
4. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins TD. 2006. The enterotoxic clostridia, p 688-752. In Dworkin M, Falkow S, Rosenburg E, Schleifer H, Stackebrandt E (ed), The prokaryotes, 3rd ed. Springer Press, New York, NY.
5. Czeczulin JR, Hanna PC, McClane BA. 1993. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect. Immun. 61:3429-3439.
6. Kitadokoro K, Nishimura K, Kamitani S, Fukui-Miyazaki A, Toshima H, Abe H, Kamata Y, Sugita-Konishi Y, Yamamoto S, Karatani H, Horiguchi Y. 2011. Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J. Biol. Chem. 286: 19549-19555. http://dx.doi.org/10.1074/jbc.M111.228478.
7. Briggs DC, Naylor CE, Smedley JG, III, Lukoyanova N, Robertson S, Moss DS, McClane BA, Basak AK. 2011. Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J. Mol. Biol. 413:138-149. http://dx.doi.org/10.1016/j.jmb.2011.07.066.
8. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. 1997. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J. Biol. Chem. 272:26652-26658. http://dx.doi.org/10.1074/jbc.272.42.26652.
9. Gao Z, McClane BA. 2012. Use of Clostridium perfringens enterotoxin and the enterotoxin receptor-binding domain (C-CPE) for cancer treatment: opportunities and challenges. J. Toxicol. 2012:981626. http://dx.doi.org/10.1155/2012/981626.
10. Shrestha A, McClane BA. 2013. Human claudin-8 and-14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin. mBio 4:e00594-12. http://dx.doi.org/10.1128/mBio.00594-12.
11. Anderson JM, Van Itallie CM. 2009. Physiology and function of the tight junction. Cold Spring Harbor Persp. Biol. 1:a002584. http://dx.doi.org/10.1101/cshperspect.a002584.
12. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. 1997. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell Biol. 136:1239-1247. http://dx.doi.org/10.1083/jcb.136.6.1239.
13. Smedley JG, III, Uzal FA, McClane BA. 2007. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun. 75:2381-2390. http://dx.doi.org/10.1128/IAI.01737-06.
14. Chen J, Theoret JR, Shrestha A, Smedley JG, III, McClane BA. 2012. Cysteine scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation. Infect. Immun. 80:4078-4088. http://dx.doi.org/10.1128/IAI.00069-12.
15. Chakrabarti G, McClane BA. 2005. The importance of calcium influx, calpain, and calmodulin for the activation of Caco-2 cell death pathways by Clostridium perfringens enterotoxin. Cell. Microbiol. 7:129-146.
16. Chakrabarti G, Zhou X, McClane BA. 2003. Death pathways activated in Caco-2 cells by Clostridium perfringens enterotoxin. Infect. Immun. 71: 4260-4270. http://dx.doi.org/10.1128/IAI.71.8.4260-4270.2003.
17. McDonel JL. 1986. Toxins of Clostridium perfringens types A, B, C, D, and E, p 477-517. In Dorner F, Drews H (ed), Pharmacology of bacterial toxins. Pergamon Press, Oxford, United Kingdom.
18. Sherman S, Klein E, McClane BA. 1994. Clostridium perfringens type A enterotoxin induces concurrent development of tissue damage and fluid accumulation in the rabbit ileum. J. Diarrheal Dis. Res. 12:200-207.
19. Smedley JG, III, Saputo J, Parker JC, Fernandez-Miyakawa ME, Robertson SL, McClane BA, Uzal FA. 2008. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun. 76:3793-3800. http://dx.doi.org/10.1128/IAI.00460-08.
20. Uzal FA, McClane BA. 2012. Animal models to study the pathogenesis of enterotoxigenic Clostridium perfringens infections. Microbes Infect. 14: 1009-1016. http://dx.doi.org/10.1016/j.micinf.2012.06.003.
21. McDonel JL, Demers GW. 1982. In vivo effects of enterotoxin from Clostridium perfringens typeAin rabbit colon: binding vs. biologic activity. J. Infect. Dis. 145:490-494. http://dx.doi.org/10.1093/infdis/145.4.490.
22. Wen Q, McClane BA. 2004. Detection of enterotoxigenic Clostridium perfringens typeAisolates in American retail foods. Appl. Environ. Microbiol. 70:2685-2691. http://dx.doi.org/10.1128/AEM.70.5.2685-2691.2004.
23. McDonel JL, McClane BA. 1988. Production, purification and assay of Clostridium perfringens enterotoxin. Method Enzymol. 165:94-103. http://dx.doi.org/10.1016/S0076-6879(88)65018-X.
24. Wnek AP, Strouse RJ, McClane BA. 1985. Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin. Infect. Immun. 50:442-448.
25. Robertson SL, Smedley JG, III, Singh U, Chakrabarti G, Van Itallie CM, Anderson JM, McClane BA. 2007. Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants. Cell. Microbiol. 9:2734-2755. http://dx.doi.org/10.1111/j.1462-5822.2007.00994.x.
26. Bartholomew BA, Stringer MF, Watson GN, Gilbert RJ. 1985. Development and application of an enzyme-linked immunosorbent assay for Clostridium perfringens type A enterotoxin. J. Clin. Pathol. 38:222-228. http://dx.doi.org/10.1136/jcp.38.2.222.
27. Berry P, Rodhouse J, Hughes S, Bartholomew B, Gilbert RJ. 1988. Evaluation of ELISA, RPLA, and Vero cell assays for detecting Clostridium perfringens enterotoxin in faecal specimens. J. Clin. Pathol. 41:458-461. http://dx.doi.org/10.1136/jcp.41.4.458.
28. Singh U, Van Itallie CM, Mitic LL, Anderson JM, McClane BA. 2000. Caco-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275:18407-18417. http://dx.doi.org/10.1074/jbc.M001530200.
29. Caserta JA, Robertson SL, Saputo J, Shrestha A, McClane BA, Uzal FA. 2011. Development and application of a mouse interstinal loop model to study the in vivo action of Clostridium perfringens enterotoxin. Infect. Immun. 79:3020-3027. http://dx.doi.org/10.1128/IAI.01342-10.
30. Bos J, Smithee L, McClane BA, Distefano RF, Uzal F, Songer JG, Mallonee S, Crutcher JM. 2005. Fatal necrotizing enteritis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. Clin. Infect. Dis. 15:78-83. http://dx.doi.org/10.1086/429829.
31. Fernandez Miyakawa ME, Pistone Creydt V, Uzal FA, McClane BA, Ibarra C. 2005. Clostridium perfringens enterotoxin damages the human intestine in vitro. Infect. Immun. 73:8407-8410. http://dx.doi.org/10.1128/IAI.73.12.8407-8410.2005.
32. Gorkiewicz G, Thallinger GG, Trajanoski S, Lackner S, Stocker G, Hinterleitner T, Gully C, Hogenauer C. 2013. Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS One 8:e55817. http://dx.doi.org/10.1371/journal.pone.0055817.
33. Clausen MR, Jørgensen J, Mortensen PB. 1998. Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Dig. Dis. Sci. 43:2696-2707. http://dx.doi.org/10.1023/A:102665 9512786.
34. Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS. 1989. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J. Clin. Invest. 84:1056-1062. http://dx.doi.org/10.1172/JCI114267.
35. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M. 2009. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G1140-G1149. http://dx.doi.org/10.1152/ajpgi.90534.2008.
36. Hewitt KJ, Agarwal R, Morin PJ. 2006. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6:186. http://dx.doi.org/10.1186/1471-2407-6-186.
37. Lu Z, Ding L, Lu Q, Chen YH. 2013. Claudins in intestines: Distribution and functional significance in health and diseases. Tissue Barriers 1:e24978. http://dx.doi.org/10.4161/tisb.24978.